{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:59:38Z","timestamp":1790510378080,"version":"4.1.0"},"reference-count":163,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","seminarsinnephrology.org","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.semnephrol.2018.02.004","type":"journal-article","created":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T22:26:58Z","timestamp":1525904818000},"page":"233-250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Updates on the Mechanisms and the Care of Cardiovascular Calcification in Chronic Kidney Disease"],"prefix":"10.1016","volume":"38","author":[{"given":"Lucie","family":"H\u00e9naut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Chillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa\u00efd","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad A.","family":"Massy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2018.02.004_bib1","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.kint.2017.07.020","article-title":"Understanding the pathogenesis of vascular calcification: timing is everything","volume":"92","author":"O'Neill","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib2","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.kint.2017.06.019","article-title":"Identifying early pathogenic events during vascular calcification in uremic rats","volume":"92","author":"Hortells","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib3","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1093\/ndt\/gfr609","article-title":"Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD","volume":"27","author":"Smith","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib4","doi-asserted-by":"crossref","first-page":"568","DOI":"10.2215\/CJN.07081009","article-title":"The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report","volume":"5","author":"Schurgers","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib5","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1681\/ASN.2004080694","article-title":"Reduced plasma pyrophosphate levels in hemodialysis patients","volume":"16","author":"Lomashvili","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib6","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib7","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0735-1097(01)01781-8","article-title":"Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?","volume":"39","author":"Raggi","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib8","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1093\/ndt\/gfq089","article-title":"Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients","volume":"25","author":"Nasrallah","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1681\/ASN.2008040349","article-title":"Association of serum phosphate with vascular and valvular calcification in moderate CKD","volume":"20","author":"Adeney","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 1","key":"10.1016\/j.semnephrol.2018.02.004_bib10","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.2215\/CJN.05860809","article-title":"Effects of calcium on cardiovascular events in patients with kidney disease and in a healthy population","volume":"5","author":"West","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib11","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib12","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2215\/CJN.06040809","article-title":"Outcomes associated with serum calcium level in men with non-dialysis-dependent chronic kidney disease","volume":"5","author":"Kovesdy","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.atherosclerosis.2017.03.005","article-title":"Free DNA precipitates calcium phosphate apatite crystals in the arterial wall in vivo","volume":"259","author":"Coscas","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib14","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/ki.2010.390","article-title":"Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro","volume":"79","author":"Sage","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib15","doi-asserted-by":"crossref","first-page":"e60904","DOI":"10.1371\/journal.pone.0060904","article-title":"Fetuin-A-containing calciprotein particles reduce mineral stress in the macrophage","volume":"8","author":"Smith","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib16","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1161\/CIRCRESAHA.108.181305","article-title":"Calcium phosphate crystals induce cell death in human vascular smooth muscle cells: a potential mechanism in atherosclerotic plaque destabilization","volume":"103","author":"Ewence","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib17","doi-asserted-by":"crossref","first-page":"e0174998","DOI":"10.1371\/journal.pone.0174998","article-title":"Novel phosphate-activated macrophages prevent ectopic calcification by increasing extracellular ATP and pyrophosphate","volume":"12","author":"Villa-Bellosta","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1681\/ASN.2009121311","article-title":"Klotho deficiency causes vascular calcification in chronic kidney disease","volume":"22","author":"Hu","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib19","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/CIRCULATIONAHA.111.053405","article-title":"Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23","volume":"125","author":"Lim","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib20","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3109\/08977194.2015.1108313","article-title":"Secreted klotho protein attenuates osteogenic differentiation of human bone marrow mesenchymal stem cells in vitro via inactivation of the FGFR1\/ERK signaling pathway","volume":"33","author":"Zhang","year":"2015","journal-title":"Growth Factors"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib21","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/ki.2015.160","article-title":"Mammalian target of rapamycin signaling inhibition ameliorates vascular calcification via Klotho upregulation","volume":"88","author":"Zhao","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib22","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.kint.2015.12.029","article-title":"Intermedin1-53 attenuates vascular calcification in rats with chronic kidney disease by upregulation of \u03b1-Klotho","volume":"89","author":"Chang","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2013.03.008","article-title":"A protective role for FGF-23 in local defence against disrupted arterial wall integrity?","volume":"372","author":"Zhu","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib24","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1172\/JCI61405","article-title":"FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality","volume":"122","author":"Shalhoub","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib25","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/ki.2013.332","article-title":"Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency","volume":"85","author":"Jimbo","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib26","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ki.2013.3","article-title":"Fibroblast growth factor 23 is not associated with and does not induce arterial calcification","volume":"83","author":"Scialla","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib27","doi-asserted-by":"crossref","first-page":"e60658","DOI":"10.1371\/journal.pone.0060658","article-title":"Arterial klotho expression and FGF23 effects on vascular calcification and function","volume":"8","author":"Lindberg","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib28","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1681\/ASN.2006121385","article-title":"Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice","volume":"18","author":"Stubbs","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1517\/14728222.2015.1081685","article-title":"Targeting local vascular and systemic consequences of inflammation on vascular and cardiac valve calcification","volume":"20","author":"H\u00e9naut","year":"2016","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib30","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1161\/01.CIR.102.21.2636","article-title":"Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway","volume":"102","author":"Tintut","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib31","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.bbrc.2009.12.027","article-title":"Tumor necrosis factor-alpha increases alkaline phosphatase expression in vascular smooth muscle cells via MSX2 induction","volume":"391","author":"Lee","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib32","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1210\/en.2007-1021","article-title":"Adiponectin antagonizes stimulatory effect of tumor necrosis factor-alpha on vascular smooth muscle cell calcification: regulation of growth arrest-specific gene 6-mediated survival pathway by adenosine 5'-monophosphate-activated protein kinase","volume":"149","author":"Son","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib33","doi-asserted-by":"crossref","first-page":"e000238","DOI":"10.1161\/JAHA.113.000238","article-title":"PERK-eIF2\u03b1-ATF4-CHOP signaling contributes to TNF\u03b1-induced vascular calcification","volume":"2","author":"Masuda","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib34","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/ki.2012.40","article-title":"Activation of nuclear factor-kappa B accelerates vascular calcification by inhibiting ankylosis protein homolog expression","volume":"82","author":"Zhao","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib35","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1681\/ASN.2010101073","article-title":"The inflammatory cytokines TWEAK and TNF\u03b1 reduce renal klotho expression through NF\u03baB","volume":"22","author":"Moreno","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib36","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.ijcard.2013.01.211","article-title":"Nalp3 inflammasome is activated and required for vascular smooth muscle cell calcification","volume":"168","author":"Wen","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib37","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/0394632016689571","article-title":"Endogenous bone morphogenetic protein 2 plays a role in vascular smooth muscle cell calcification induced by interleukin 6 in vitro","volume":"30","author":"Sun","year":"2017","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib38","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000358920","article-title":"Increased calcification in osteoprotegerin-deficient smooth muscle cells: dependence on receptor activator of NF-\u03baB ligand and interleukin 6","volume":"51","author":"Callegari","year":"2014","journal-title":"J Vasc Res"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib39","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1523-1755.2005.00200.x","article-title":"IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly","volume":"67","author":"Stenvinkel","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib40","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/ndt\/gfn571","article-title":"Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences","volume":"24","author":"Jean","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.carpath.2017.01.004","article-title":"Vascular inflammation and media calcification are already present in early stages of chronic kidney disease","volume":"27","author":"Benz","year":"2017","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1155\/2013\/846059","article-title":"Biomarkers associated with vascular and valvular calcification in chronic hemodialysis patients","volume":"34","author":"Lee","year":"2013","journal-title":"Dis Markers"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib43","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/ndt\/17.9.1684","article-title":"Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment","volume":"17","author":"Pecoits-Filho","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib44","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.kint.2016.05.019","article-title":"Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease","volume":"90","author":"Singh","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib45","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/1521-3803(20010601)45:3<172::AID-FOOD172>3.0.CO;2-U","article-title":"Advanced glycation endproducts (AGEs) as uremic toxins","volume":"45","author":"Schwenger","year":"2001","journal-title":"Nahrung"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib46","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.1523-1755.1999.00302.x","article-title":"Alterations in nonenzymatic biochemistry in uremia: origin and significance of \"carbonyl stress\" in long-term uremic complications","volume":"55","author":"Miyata","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib47","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1046\/j.1523-1755.2000.00117.x","article-title":"Mechanisms for the formation of glycoxidation products in end-stage renal disease","volume":"57","author":"Weiss","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib48","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0272-6386(03)00779-0","article-title":"Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients","volume":"42","author":"Uribarri","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib49","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/01.ASN.0000051593.41395.B9","article-title":"Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients","volume":"14","author":"Uribarri","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib50","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1159\/000226225","article-title":"Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE\/p38 MAPK","volume":"46","author":"Tanikawa","year":"2009","journal-title":"J Vasc Res"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib51","first-page":"4644","article-title":"AGE\/RAGE promotes the calcification of human aortic smooth muscle cells via the Wnt\/\u03b2-catenin axis","volume":"8","author":"Liu","year":"2016","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib52","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s00125-014-3348-z","article-title":"RANKL-OPG and RAGE modulation in vascular calcification and diabetes: novel targets for therapy","volume":"57","author":"Ndip","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib53","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1046\/j.1523-1755.2001.59780032.x","article-title":"Inflammation and advanced glycation end products in uremia: simple coexistence, potentiation or causal relationship?","volume":"78","author":"Schwedler","year":"2001","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib54","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/hc0702.104183","article-title":"Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses","volume":"105","author":"Basta","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib55","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2215\/CJN.03980609","article-title":"Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients","volume":"4","author":"Barreto","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib56","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.kint.2017.05.012","article-title":"Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated with cardiovascular outcomes","volume":"92","author":"Shafi","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib57","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1093\/ndt\/gfm861","article-title":"Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats","volume":"23","author":"Adijiang","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib58","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3109\/0886022X.2016.1155397","article-title":"Indoxyl sulfate promotes vascular smooth muscle cell calcification via the JNK\/Pit-1 pathway","volume":"38","author":"Wu","year":"2016","journal-title":"Ren Fail"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib59","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1093\/ndt\/gfn757","article-title":"Indoxyl sulphate induces oxidative stress and the expression of osteoblast-specific proteins in vascular smooth muscle cells","volume":"24","author":"Muteliefu","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib60","doi-asserted-by":"crossref","first-page":"C126","DOI":"10.1152\/ajpcell.00329.2011","article-title":"Indoxyl sulfate promotes vascular smooth muscle cell senescence with upregulation of p53, p21, and prelamin A through oxidative stress","volume":"303","author":"Muteliefu","year":"2012","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib61","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1093\/ndt\/gfv250","article-title":"Indoxyl sulfate suppresses hepatic fetuin-A expression via the aryl hydrocarbon receptor in HepG2 cells","volume":"30","author":"Ochi","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib62","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10157-012-0717-0","article-title":"Association between AST-120 and abdominal aortic calcification in predialysis patients with chronic kidney disease","volume":"17","author":"Goto","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib63","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00223-013-9712-z","article-title":"Vascular calcification: an update on mechanisms and challenges in treatment","volume":"93","author":"Wu","year":"2013","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib64","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1681\/ASN.2004060512","article-title":"Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study","volume":"16","author":"Lindberg","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib65","doi-asserted-by":"crossref","first-page":"F946","DOI":"10.1152\/ajprenal.00474.2006","article-title":"Extracellular calcium-sensing receptor is functionally expressed in human artery","volume":"293","author":"Molostvov","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib66","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2008.10.043","article-title":"The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE-\/-) mice","volume":"205","author":"Ivanovski","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib67","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/cvr\/cvn279","article-title":"Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cells","volume":"81","author":"Alam","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib68","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00223-010-9442-4","article-title":"Effect of calcium and the calcimimetic AMG 641 on matrix-Gla protein in vascular smooth muscle cells","volume":"88","author":"Mendoza","year":"2011","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib69","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000349935","article-title":"The calcimimetic calindol prevents high phosphate-induced vascular calcification by upregulating matrix GLA protein","volume":"122","author":"Ciceri","year":"2012","journal-title":"Nephron Exp Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib70","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/cvr\/cvt249","article-title":"Calcimimetics increase CaSR expression and reduce mineralization in vascular smooth muscle cells: mechanisms of action","volume":"101","author":"H\u00e9naut","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib71","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/ndt\/gfq725","article-title":"The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis","volume":"26","author":"Raggi","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib72","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"Chertow","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib73","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.2016.19456","article-title":"Effect of etelcalcetide vs placebo on serum parathyroid hormone in patients receiving hemodialysis with secondary hyperparathyroidism: two randomized clinical trials","volume":"317","author":"Block","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib74","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1517\/14740338.2014.907791","article-title":"Phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a comparison of safety profiles","volume":"13","author":"Locatelli","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib75","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1159\/000192844","article-title":"Blockage of the renin-angiotensin system attenuates mortality but not vascular calcification in uremic rats: sevelamer carbonate prevents vascular calcification","volume":"29","author":"Tokumoto","year":"2009","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib76","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/ndt\/gfr254","article-title":"Lanthanum carbonate, like sevelamer-HCl, retards the progression of vascular calcification and atherosclerosis in uremic apolipoprotein E-deficient mice","volume":"27","author":"Nikolov","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib77","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1161\/CIRCULATIONAHA105.541854","article-title":"Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice","volume":"112","author":"Phan","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib78","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1523-1755.2005.00600.x","article-title":"Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis","volume":"68","author":"Block","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib79","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib80","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1681\/ASN.2012030223","article-title":"Effects of phosphate binders in moderate CKD","volume":"23","author":"Block","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib81","doi-asserted-by":"crossref","first-page":"c273","DOI":"10.1159\/000170783","article-title":"Phosphate binder impact on bone remodeling and coronary calcification--results from the BRiC study","volume":"110","author":"Barreto","year":"2008","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib82","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1053\/j.ajkd.2008.02.298","article-title":"A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study","volume":"51","author":"Qunibi","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib83","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s10157-012-0725-0","article-title":"The effects of iron on FGF23-mediated Ca-P metabolism in CKD patients","volume":"17","author":"Deger","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib84","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2215\/CJN.08230811","article-title":"Randomized clinical trial of the iron-based phosphate binder PA21 in hemodialysis patients","volume":"8","author":"W\u00fcthrich","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib85","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1124\/jpet.113.204792","article-title":"PA21, a new iron-based noncalcium phosphate binder, prevents vascular calcification in chronic renal failure rats","volume":"346","author":"Phan","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib86","doi-asserted-by":"crossref","first-page":"515606","DOI":"10.1155\/2015\/515606","article-title":"Effects of sucroferric oxyhydroxide compared to lanthanum carbonate and sevelamer carbonate on phosphate homeostasis and vascular calcifications in a rat model of chronic kidney failure","volume":"2015","author":"Phan","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib87","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1681\/ASN.2016101053","article-title":"Effects of ferric citrate in patients with nondialysis-dependent CKD and iron deficiency anemia","volume":"28","author":"Fishbane","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib88","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000348805","article-title":"Ferric citrate hydrate, a new phosphate binder, prevents the complications of secondary hyperparathyroidism and vascular calcification","volume":"37","author":"Iida","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib89","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1111\/j.1538-7836.2007.02758.x","article-title":"Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification","volume":"5","author":"Schurgers","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib90","doi-asserted-by":"crossref","first-page":"590","DOI":"10.2215\/CJN.06420909","article-title":"Vitamins K and D status in stages 3-5 chronic kidney disease","volume":"5","author":"Holden","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib91","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/ki.2013.530","article-title":"Impaired vitamin K recycling in uremia is rescued by vitamin K supplementation","volume":"86","author":"Kaesler","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib92","doi-asserted-by":"crossref","first-page":"6991","DOI":"10.3390\/nu7085318","article-title":"High-dose menaquinone-7 supplementation reduces cardiovascular calcification in a murine model of extraosseous calcification","volume":"7","author":"Scheiber","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib93","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1053\/j.ajkd.2011.10.041","article-title":"Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial","volume":"59","author":"Westenfeld","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib94","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1681\/ASN.2010040339","article-title":"Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD","volume":"22","author":"Schlieper","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib95","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/ndt\/gft459","article-title":"Vitamin K1 to slow vascular calcification in haemodialysis patients (VitaVasK trial): a rationale and study protocol","volume":"29","author":"Krueger","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib96","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40697-015-0053-x","article-title":"Inhibiting the progression of arterial calcification with vitamin K in HemoDialysis patients (iPACK-HD) trial: rationale and study design for a randomized trial of vitamin K in patients with end stage kidney disease","volume":"2","author":"Holden","year":"2015","journal-title":"Can J Kidney Health Dis"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib97","doi-asserted-by":"crossref","first-page":"8905","DOI":"10.3390\/nu7115443","article-title":"Menaquinone-7 supplementation to reduce vascular calcification in patients with coronary artery disease: rationale and study protocol (VitaK-CAC Trial)","volume":"7","author":"Vossen","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib98","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ki.1987.222","article-title":"Serum magnesium level and arterial calcification in end-stage renal disease","volume":"32","author":"Meema","year":"1987","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib99","doi-asserted-by":"crossref","first-page":"222","DOI":"10.5414\/CNP68222","article-title":"Significant association between the presence of peripheral vascular calcification and lower serum magnesium in hemodialysis patients","volume":"68","author":"Ishimura","year":"2007","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12882-017-0549-y","article-title":"Lower serum magnesium is associated with vascular calcification in peritoneal dialysis patients: a cross sectional study","volume":"18","author":"Molnar","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib101","doi-asserted-by":"crossref","first-page":"e89525","DOI":"10.1371\/journal.pone.0089525","article-title":"Magnesium inhibits Wnt\/\u03b2-catenin activity and reverses the osteogenic transformation of vascular smooth muscle cells","volume":"9","author":"Montes de Oca","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib102","doi-asserted-by":"crossref","first-page":"7419524","DOI":"10.1155\/2016\/7419524","article-title":"Magnesium attenuates phosphate-induced deregulation of a MicroRNA signature and prevents modulation of Smad1 and osterix during the course of vascular calcification","volume":"2016","author":"Louvet","year":"2016","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib103","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/HJH.0000000000001202","article-title":"Inhibition of osteo\/chondrogenic transformation of vascular smooth muscle cells by MgCl2 via calcium-sensing receptor","volume":"35","author":"Alesutan","year":"2017","journal-title":"J Hypertens"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib104","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF02408533","article-title":"Effect of magnesium on lipid-induced calcification: an in vitro model for bone mineralization","volume":"32","author":"Boskey","year":"1980","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib105","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0003-9861(70)90072-X","article-title":"Calcium phosphate formation in vitro. II. Effects of environment on amorphous-crystalline transformation","volume":"140","author":"Termine","year":"1970","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib106","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/ndt\/gfs520","article-title":"Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cells","volume":"28","author":"Louvet","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib107","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1124\/jpet.115.228106","article-title":"Magnesium modifies the impact of calcitriol treatment on vascular calcification in experimental chronic kidney disease","volume":"355","author":"Zelt","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib108","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.kint.2017.04.011","article-title":"Dietary magnesium supplementation prevents and reverses vascular and soft tissue\u00a0calcifications in uremic rats","volume":"92","author":"Diaz-Tocados","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib109","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1023\/A:1006814609769","article-title":"Activation of the neutrophil and loss of plasma glutathione during Mg-deficiency--modulation by nitric oxide synthase inhibition","volume":"176","author":"Mak","year":"1997","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0925-4439(00)00018-1","article-title":"Inflammatory response following acute magnesium deficiency in the rat","volume":"1501","author":"Malpuech-Brug\u00e8re","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib111","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1684\/mrh.2013.0341","article-title":"Magnesium deficiency regulates vitamin D metabolizing enzymes and type II sodium-phosphate cotransporter mRNA expression in rats","volume":"26","author":"Matsuzaki","year":"2013","journal-title":"Magnes Res"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib112","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1007\/s00198-006-0104-3","article-title":"Reduction of dietary magnesium by only 50% in the rat disrupts bone and mineral metabolism","volume":"17","author":"Rude","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib113","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1542-4758.2009.00364.x","article-title":"Long-term effects of magnesium carbonate on coronary artery calcification and bone mineral density in hemodialysis patients: a pilot study","volume":"13","author":"Spiegel","year":"2009","journal-title":"Hemodial Int"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib114","first-page":"162","article-title":"Proceedings: effect of magnesium on secondary hyperparathyroidism in chronic hemodialysis: a case with soft tissue calcification improved by high Mg dialysate","volume":"15","author":"Izawa","year":"1974","journal-title":"Calcif Tissue Res"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib115","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1007\/s11255-014-0751-9","article-title":"Magnesium retards the progress of the arterial calcifications in hemodialysis patients: a pilot study","volume":"46","author":"Tzanakis","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib116","doi-asserted-by":"crossref","first-page":"e016795","DOI":"10.1136\/bmjopen-2017-016795","article-title":"The effect of magnesium supplementation on vascular calcification in chronic kidney disease-a randomised clinical trial (MAGiCAL-CKD): essential study design and rationale","volume":"7","author":"Bressendorff","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib117","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/ki.1997.128","article-title":"Plasma mevalonate concentrations in uremic patients","volume":"51","author":"Scoppola","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib118","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.juro.2007.11.042","article-title":"Effect of simvastatin in apolipoprotein E deficient mice with surgically induced chronic renal failure","volume":"179","author":"Ivanovski","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib119","doi-asserted-by":"crossref","first-page":"917","DOI":"10.5551\/jat.23218","article-title":"Pravastatin and olmesartan synergistically ameliorate renal failure-induced vascular calcification","volume":"21","author":"Iijima","year":"2014","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib120","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1161\/ATVBAHA.107.140673","article-title":"Farnesyltransferase inhibitor, manumycin a, prevents atherosclerosis development and reduces oxidative stress in apolipoprotein E-deficient mice","volume":"27","author":"Sugita","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib121","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.atherosclerosis.2013.02.041","article-title":"Farnesyltransferase inhibitor R115777 protects against vascular disease in uremic mice","volume":"229","author":"Nikolov","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib122","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1586\/17512433.2015.1011125","article-title":"Statins stimulate atherosclerosis and heart failure: pharmacological mechanisms","volume":"8","author":"Okuyama","year":"2015","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib123","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.2337\/dc12-0464","article-title":"Progression of vascular calcification is increased with statin use in the Veterans Affairs Diabetes Trial (VADT)","volume":"35","author":"Saremi","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib124","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jacc.2015.01.036","article-title":"Impact of statins on serial coronary calcification during atheroma progression and regression","volume":"65","author":"Puri","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib125","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/j.jacc.2016.08.040","article-title":"Statin medication enhances progression of coronary artery calcification: the Heinz Nixdorf Recall Study","volume":"68","author":"Dykun","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib126","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ijcard.2015.02.072","article-title":"High dose and long-term statin therapy accelerate coronary artery calcification","volume":"184","author":"Henein","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib127","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/eci.12718","article-title":"Does statins promote vascular calcification in chronic kidney disease?","volume":"47","author":"Chen","year":"2017","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib128","doi-asserted-by":"crossref","first-page":"16666","DOI":"10.1073\/pnas.1202529109","article-title":"Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome","volume":"109","author":"Gordon","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib129","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s11255-012-0271-4","article-title":"Cardiovascular risk biomarkers in CKD: the inflammation link and the road less traveled","volume":"44","author":"Elewa","year":"2012","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib130","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nrneph.2012.41","article-title":"Monocyte subpopulations and cardiovascular risk in chronic kidney disease","volume":"8","author":"Heine","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib131","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000186276","article-title":"Acute-phase proteins during hemodialysis: correlations with serum interleukin-1 beta levels and different dialysis membranes","volume":"57","author":"Honkanen","year":"1991","journal-title":"Nephron"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib132","first-page":"63","article-title":"Plasma interleukin-1 activity in humans undergoing hemodialysis with regenerated cellulosic membranes","volume":"6","author":"Lonnemann","year":"1987","journal-title":"Lymphokine Res"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib133","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/eci.12559","article-title":"High cut-off dialysis in chronic haemodialysis patients","volume":"45","author":"Girndt","year":"2015","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib134","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000356224","article-title":"Elimination of middle-sized uremic solutes with high-flux and high-cut-off membranes: a randomized in vivo study","volume":"36","author":"Kneis","year":"2013","journal-title":"Blood Purif"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib135","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/hdi.12494","article-title":"Impact of serum and dialysates obtained from chronic hemodialysis patients maintained on high cut-off membranes on inflammation profile in human THP-1 monocytes","volume":"21","author":"Trojanowicz","year":"2017","journal-title":"Hemodial Int"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib136","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM199109193251202","article-title":"Advanced glycosylation end products in patients with diabetic nephropathy","volume":"325","author":"Makita","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib137","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/ndt\/16.5.999","article-title":"Influence of dialysis modalities on serum AGE levels in end-stage renal disease patients","volume":"16","author":"Stein","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib138","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/ki.1997.124","article-title":"Clearance of pentosidine, an advanced glycation end product, by different modalities of renal replacement therapy","volume":"51","author":"Miyata","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib139","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1046\/j.1523-1755.2000.00436.x","article-title":"Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids","volume":"58","author":"Ueda","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib140","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2215\/CJN.07750814","article-title":"Effects of sevelamer carbonate on advanced glycation end products and antioxidant\/pro-oxidant status in patients with diabetic kidney disease","volume":"10","author":"Yubero-Serrano","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib141","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.stem.2014.11.004","article-title":"Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis","volume":"16","author":"Kramann","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib142","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.stem.2016.08.001","article-title":"Adventitial MSC-like cells are progenitors of vascular smooth muscle cells and drive vascular calcification in chronic kidney disease","volume":"19","author":"Kramann","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib143","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/ckj\/sfv145","article-title":"Calcifying circulating cells: an uncharted area in the setting of vascular calcification in CKD patients","volume":"9","author":"Cianciolo","year":"2016","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib144","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1161\/CIRCULATIONAHA.112.090860","article-title":"Emerging role of circulating calcifying cells in the bone-vascular axis","volume":"125","author":"Fadini","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib145","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/ar130","article-title":"Mesenchymal precursor cells in the blood of normal individuals","volume":"2","author":"Zvaifler","year":"2000","journal-title":"Arthritis Res"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib146","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1083\/jcb.153.5.1133","article-title":"Circulating skeletal stem cells","volume":"153","author":"Kuznetsov","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib147","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.bbrc.2006.12.226","article-title":"Bone marrow-derived osteoblast progenitor cells in circulating blood contribute to ectopic bone formation in mice","volume":"354","author":"Otsuru","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib148","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1634\/stemcells.2007-0515","article-title":"Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4\/stromal cell-derived factor-1 pathway","volume":"26","author":"Otsuru","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib149","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/jor.21167","article-title":"Circulating plastic adherent mesenchymal stem cells in aged hip fracture patients","volume":"28","author":"Alm","year":"2010","journal-title":"J Orthop Res"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib150","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00198-007-0539-1","article-title":"Progression of vascular calcifications is associated with greater bone loss and increased bone fractures","volume":"19","author":"Naves","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib151","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000347102","article-title":"Effect of vitamin D receptor activator therapy on vitamin D receptor and osteocalcin expression in circulating endothelial progenitor cells of hemodialysis patients","volume":"35","author":"Cianciolo","year":"2013","journal-title":"Blood Purif"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib152","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1161\/CIRCRESAHA.110.234088","article-title":"Widespread increase in myeloid calcifying cells contributes to ectopic vascular calcification in type 2 diabetes","volume":"108","author":"Fadini","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib153","first-page":"301","article-title":"Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis","volume":"140","author":"Clinton","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib154","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/ATVBAHA.110.222547","article-title":"Runx2-upregulated receptor activator of nuclear factor \u03baB ligand in calcifying smooth muscle cells promotes migration and osteoclastic differentiation of macrophages","volume":"31","author":"Byon","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib155","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s004280050289","article-title":"Observations on bone formation and remodelling in advanced atherosclerotic lesions of human carotid arteries","volume":"433","author":"Jeziorska","year":"1998","journal-title":"Virchows Arch"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib156","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.yexmp.2015.11.010","article-title":"Multinucleated giant cells in atherosclerotic plaques of human carotid arteries: identification of osteoclast-like cells and their specific proteins in artery wall","volume":"99","author":"Qiao","year":"2015","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib157","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.carpath.2006.07.001","article-title":"Toward cell therapy for vascular calcification: osteoclast-mediated demineralization of calcified elastin","volume":"16","author":"Simpson","year":"2007","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib158","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.yjmcc.2005.03.019","article-title":"Regulation of RANKL-induced osteoclastic differentiation by vascular cells","volume":"39","author":"Tintut","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib159","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/jcp.21283","article-title":"High extracellular inorganic phosphate concentration inhibits RANK-RANKL signaling in osteoclast-like cells","volume":"215","author":"Mozar","year":"2008","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib160","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1093\/ndt\/gfr647","article-title":"Indoxyl sulphate inhibits osteoclast differentiation and function","volume":"27","author":"Mozar","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib161","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/CIRCRESAHA.117.311219","article-title":"Macrophage heterogeneity complicates reversal of calcification in cardiovascular tissues","volume":"121","author":"Rogers","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib162","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/CIRCRESAHA.116.310262","article-title":"Human alternative macrophages populate calcified areas of atherosclerotic lesions and display impaired RANKL-induced osteoclastic bone resorption activity","volume":"121","author":"Chinetti-Gbaguidi","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.semnephrol.2018.02.004_bib163","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.ajpath.2017.02.012","article-title":"Interferon-\u03b3 released by activated CD8(+) T lymphocytes impairs the calcium resorption potential of osteoclasts in calcified human aortic valves","volume":"187","author":"Nagy","year":"2017","journal-title":"Am J Pathol"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929518300251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929518300251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T20:12:26Z","timestamp":1604261546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929518300251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":163,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0270929518300251"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2018.02.004","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updates on the Mechanisms and the Care of Cardiovascular Calcification in Chronic Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2018.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}